HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL

I Suc1, I Escargueil-Blanc, M Troly

  • 1Department of Biochemistry, INSERM U.466, IFR Louis Bugnard, University Paul Sabatier, Toulouse, France.

Insights

High-density lipoprotein (HDL), primarily apolipoprotein A-I (apoA-I), protects endothelial cells from oxidized low-density lipoprotein (LDL) toxicity. HDL blocks the calcium ion (Ca2+) rise that causes cell death.

Area of Science:

  • Cardiovascular Biology
  • Cellular Signaling
  • Lipoprotein Metabolism

Background:

  • Oxidized low-density lipoprotein (oxLDL) induces a sustained rise in cytosolic calcium ions (Ca2+), leading to endothelial cell damage and death.
  • High-density lipoprotein (HDL) and its major apolipoprotein, apoA-I, have shown protective effects against cellular damage.

Purpose of the Study:

  • To investigate the protective mechanism of HDL against oxLDL-induced endothelial cell toxicity.
  • To determine the role of apolipoproteins and HDL-cell interaction in this protective effect.

Main Methods:

  • Cell culture experiments using bovine aortic endothelial cells.
  • Treatment with oxidized low-density lipoprotein (oxLDL), high-density lipoprotein (HDL), and isolated apolipoproteins (apoA-I, apoA-II).
  • Measurement of cytosolic Ca2+ levels and assessment of cell viability and protein synthesis.

Main Results:

  • HDL and apoA-I effectively prevented oxLDL-induced cell death in a time- and dose-dependent manner.
  • The protective effect was mediated by HDL's direct interaction with cells, not by inhibiting oxLDL itself.
  • HDL/apoA-I pre-incubation enhanced endothelial cell resistance to oxLDL by inhibiting the pathogenic Ca2+ influx.

Conclusions:

  • HDL, primarily through apoA-I, confers resistance to endothelial cells against oxLDL toxicity.
  • HDL acts by modulating intracellular signaling pathways, specifically blocking the sustained Ca2+ rise critical for oxLDL-induced apoptosis.

Related Concept Videos

Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
Inflammation01:38

Inflammation

Overview
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...